Rotavirus infection

Rotavirus infection is a viral infection caused by rotavirus and is recognized in surveillance terms as a rotavirus infection concept ^[1][3]. The available source material characterizes it primarily as an acute diarrheal and gastroenteritis syndrome rather than a localized or chronic disease ^[1][2]. Published reviews in the source set indicate that current oral rotavirus vaccines have a positive protective association, but detailed vaccine performance or schedule information is not provided in the snippets ^[2].

The core clinical syndrome is severe, dehydrating gastroenteritis with diarrhea, and the disease can produce clinically significant fluid loss ^[1]. The abstracted pathophysiology in the sources links diarrhea to destruction of absorptive enterocytes with malabsorption, intestinal secretion stimulated by rotavirus non-structural protein 4, and activation of the enteric nervous system ^[1]. The sources also note antigenaemia and viraemia, with antigenaemia associated with more severe acute gastroenteritis, and limited replication at systemic sites ^[1]. Reinfection is common throughout life, although severity is reduced with repeat infections ^[1]. The source set additionally reports historical links with autoimmunity, including associations with celiac disease and diabetes, but it does not establish causality ^[2].

Rotavirus infection is reported worldwide and is described as a major etiologic agent of acute diarrhea in children across settings ^[2]. The strongest disease burden in the provided evidence is in children under 5 years of age, and mortality remains high despite vaccine introduction ^[1]. More than 200,000 deaths annually are reported, mostly in low-income countries ^[1]. The snippets do not provide outbreak timing, seasonal patterns, reservoir details, or additional population-level surveillance parameters beyond this global burden framing ^[1][2].

The provided sources do not give a direct description of transmission route, environmental persistence, or exposure mechanism. They do show that the infection targets enterocytes and is associated with diarrheal illness, but source-backed detail on how person-to-person spread occurs is not yet available in the supplied material ^[1].

The clearest risk group supported by the sources is children under 5 years of age, who are described as the main population affected by severe rotavirus gastroenteritis ^[1]. The mortality burden is reported to be concentrated in low-income countries ^[1]. The source material also notes that reinfections occur throughout life, although without further specification of high-risk subgroups ^[1].

The source set indicates that rotavirus vaccines have been globally introduced and that current oral rotavirus vaccines have a positive protective association ^[1][2]. Beyond vaccination, the snippets do not specify other prevention measures such as hygiene, sanitation, isolation, or outbreak-control practices. Source-backed detail on vaccine schedule, target groups, or programmatic implementation is not yet available in the supplied material ^[1][2].

In surveillance use, rotavirus infection should be read as a leading pediatric cause of severe dehydrating diarrhea with persistent global mortality despite vaccine availability ^[1]. The disease burden is especially important in children under 5 years and in low-income countries, and repeat infection can occur across the life course ^[1]. The current source set supports monitoring of severe gastroenteritis outcomes and mortality, but it does not provide detailed case definitions, laboratory thresholds, or seasonality for operational surveillance ^[1][2].

1. 1 Crawford SE et al. Rotavirus infection. Nat Rev Dis Primers. 2017 Nov 9. PMID: 29119972. doi: 10.1038/nrdp.2017.83. PubMed: https://pubmed.ncbi.nlm.nih.gov/29119972/
2. 2 Gómez-Rial J et al. Rotavirus and autoimmunity. J Infect. 2020 Aug. PMID: 32360880. doi: 10.1016/j.jinf.2020.04.041. PubMed: https://pubmed.ncbi.nlm.nih.gov/32360880/
3. 3 Rotavirus infection. Russian Pediatric Journal. 2023. doi: 10.15690/rpj.v4i3.2566. DOI: https://doi.org/10.15690/rpj.v4i3.2566
4. 4 Rotavirus Vaccines. PubMed indexed record. 2006. PMID: 30000693. PubMed: https://pubmed.ncbi.nlm.nih.gov/30000693/
5. 5 Rotavirus Infection. Advances in Pediatrics. 2012. doi: 10.1016/j.yapd.2012.04.002. DOI: https://doi.org/10.1016/j.yapd.2012.04.002
6. 6 Rotavirus Infection. Netter’s Infectious Diseases. 2012. doi: 10.1016/b978-1-4377-0126-5.00009-4. DOI: https://doi.org/10.1016/b978-1-4377-0126-5.00009-4

ICD-10

A08.0

ICD-11

Total cases

20K

Peak month

2010-08

Coverage

1 reporting countries · 2009-01-01 → 2026-04-01